Access to medicines: Cost as an influence on the views and behaviour of patients

Health and Social Care in the Community

Volumn 10, Issue 3, 2002, Pages 187-195

  Schafheutle, Ellen I ^a   Hassell, Karen ^a   Noyce, Peter R ^a   Weiss, Marjorie C ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cost sharing; Health services accessibility; Medication prescription fees; Patient behaviour; Prescription charges

Indexed keywords

ESSENTIAL DRUG;

ADULT; AGED; ARTICLE; COST; DECISION MAKING; DOCTOR PATIENT RELATION; ECONOMICS; FEE; FEMALE; HEALTH CARE DELIVERY; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; COMMUNICATION; COST SHARING; DECISION MAKING; DRUGS, ESSENTIAL; ENGLAND; FEES, PHARMACEUTICAL; FEMALE; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS;

EID: 0036560589     PISSN: 09660410     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2524.2002.00356.x     Document Type: Article

References (37)

1. Anonymous (2000) Antihypertensive compliance and stroke risk. Pharmaceutical Journal 265, 642.
2. Barry C. A., Bradley C.P., Britten N., Stevenson F. A. & Barber N. (2000) Patients' unvoiced agendas in general practice consultations: qualitative study. British Medical Journal 320, 1246-1250.
3. Beardon P.H.G., McGilchrist M.M., McKendrick A.D., McDevitt D.G. & MacDonald T.M. (1993) Primary non-compliance with prescribed medication in primary care. British Medical Journal 307, 846-848.
4. Begg D. (1984) Do patients cash their prescriptions? An audit in one practice. Journal of the Royal College of General Practitioners 34, 272-274.
5. Bissell P., Ward P.R. & Noyce P.R. (1997) Variation within community pharmacy. 3. Referring customers to other health professionals. Journal of Social and Administrative Pharmacy 14, 116-123.
6. Bowling A. (1997) Research Methods in Health, Investigating Health and Health Services. Open University Press, Buckingham.
7. Bradley C.P., Riaz A., Tobias R.S., Kenkre J.E. & Dassu D.Y. (1998) Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Family Practice 15, 44-50.
8. British Medical Association General Practitioners' Committee (2001) The Future of Prescribing. Discussion Paper. British Medical Association, London.
9. Department of Health (1999) Statistics of Prescriptions Dispensed in the Community: England 1988 to 1998. Statistical Bulletin 1999/17. Department of Health, London.
10. Department of Health (2000) Pharmacy in the Future Implementing the NHS Plan. Department of Health, London.
11. Donovan J.L. & Blake D.R. (1992) Patient non-compliance: deviance or reasoned decision-making? Social Science and Medicine 34, 507-513.
12. Gosden T. & Torgerson D.J. (1997) The effect of fundholding on prescribing and referral costs: a review of the evidence. Health Policy 40, 103-114.
13. Hassell K. & Hibbert D. (1996) The use of focus groups in pharmacy research: processes and practicalities. Journal of Social and Administrative Pharmacy 13, 169-177.
14. Hassell K., Noyce P.R. & Rogers A. (1999) A review of factors that influence the use of community pharmacies as primary health care resource. International Journal of Pharmacy Practice 7, 51-59.
15. Horwitz R.I., Viscoli C.M., Berkman L., Donaldson R.M., Horwitz S.M., Murray C.J., Ransohoff D.F. & Sindelar J. (1990) Treatment adherence and risk of death after a myocardial infarction. Lancet 336, 542-545.
16. Hughes D. & McGuire A. (1995) Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure. Health Economics 4, 213-220.
17. Jones I. & Britten N. (1998) Why do some patients not cash their prescriptions? British Journal of General Practice 48, 903-905.
18. Jones R. & Lydeard S. (1989) Prevalence of symptoms of dyspepsia in the community. British Medical Journal 298, 30-32.
19. Krueger R.A. (1994) Focus Groups. A Practical Guide for Applied Research. Sage Publications, Thousand Oaks, CA.
20. Lipid Research Clinics Program (1984) The Lipid Research Clinic Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Journal of the American Medical Association 251, 365-374.
21. Mossialos E. & Le Grand J. (1999) Cost containment in the EU: an overview. In: E. Mossialos and J. Le Grand (Eds) Health Care and Cost Containment in the European Union, pp. 1-154. Ashgate, Aldershot.
22. Nathan A. (1996) A non-prescription medicines formulary. 4. Hay fever treatments. Pharmaceutical Journal 256, 188-191.
23. Noyce P.R., Huttin C., Atella V., Brenner G., Haaijer-Ruskamp P.M., Hedvall M.-B. & Mechtler R. (2000) The cost of prescription medicines to patients. Health Policy 52, 129-145.
24. O'Brien B. (1989) The effect of patient charges on the utilization of prescription medicines. Journal of Health Economics 8, 109-132.
25. Phelps L. (2001) Unhealthy Charges. CAB Evidence on the Impact of Health Charges, National Association of Citizens Advice Bureaux, London.
26. Psaty B.M., Koepsell T.D., Wagner E.H., LoGerfo J.P. & Inui T.S. (1990) The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. Journal of the American Medical Association 263,1653-1657.
27. Ritchie J. & Spencer L. (1994) Qualitative data analysis for applied policy research. In: A. Bryman and R. G. Burgess (Eds) Analyzing Qualitative Data, p. 232. Routledge, London.
28. Royal Pharmaceutical Society of Great Britain (1997) From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. Royal Pharmaceutical Society, London.
29. Ryan M. & Birch S. (1991) Charging for health care: evidence on the utilisation of NHS prescribed drugs. Social Science and Medicine 33, 681-687.
30. Schafheutle E.I., Hassell K., Seston E.M. & Noyce P.R. (2002) Non-dispensing of NHS prescriptions in community pharmacies. International Journal of Pharmacy Practice 10, 11-15.
31. Soumerai S.B., Avorn J., Ross-Degnan D. & Gortmaker S. (1987) Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. New England Journal of Medicine 317, 550-556.
32. Stevenson F.A., Greenfield S.M., Jones M., Nayak A. & Bradley C.P. (1999) GPs' perceptions of patient influence on prescribing. Family Practice 16, 255-261.
33. Stuart B. & Grana J. (1998) Ability to pay and the decision to medicate. Medical Care 36, 202-211.
34. Tamblyn R., Laprise R., Hanley J.A., Abrahamowicz M., Scott S., Mayo N., Hurley J., Grad R., Latimer E., Perreault R., McLeod P., Huang A., Larochelle P. & Mallet L. (2001) Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Journal of the American Medical Association 285, 421-429.
35. Tuckett D., Boulton M., Olson C. & Williams A. (1985) Meetings Between Experts: An Approach to Sharing Ideas in Medical Consultations. Tavistock Publications, London.
36. Weiss M.C., Fitzpatrick R., Scott D.K. & Goldacre M.J. (1996) Pressures on the general practitioner and decisions to prescribe. Family Practice 13, 432-438.
37. Weiss M.C., Hassell K., Schafheutle E.I. & Noyce P.R. (2001) Strategies used by general practitioners to minimise the impact of the prescription charge. European Journal of General Practice 7, 23-26.